Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Ophthalmology Drugs & Devices Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Diagnostic and monitoring devices
  • 1.3.3 Surgical devices
  • 1.3.4 Vision care
  • 1.3.5 Drugs
• 1.4 Market Segment by Application
  • 1.4.1 Global Ophthalmology Drugs & Devices Market Share by Application (2019-2025)
  • 1.4.2 Cataract
  • 1.4.3 Glaucoma
  • 1.4.4 Refractive error
  • 1.4.5 Vitreoretinal
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Ophthalmology Drugs & Devices Production Value 2014-2025
  • 2.1.2 Global Ophthalmology Drugs & Devices Production 2014-2025
  • 2.1.3 Global Ophthalmology Drugs & Devices Capacity 2014-2025
  • 2.1.4 Global Ophthalmology Drugs & Devices Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Ophthalmology Drugs & Devices Market Size CAGR of Key Regions
  • 2.2.2 Global Ophthalmology Drugs & Devices Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Ophthalmology Drugs & Devices Capacity by Manufacturers
  • 3.1.2 Global Ophthalmology Drugs & Devices Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Ophthalmology Drugs & Devices Revenue by Manufacturers (2014-2019)
  • 3.2.2 Ophthalmology Drugs & Devices Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Ophthalmology Drugs & Devices Market Concentration Ratio (CR5 and HHI)
• 3.3 Ophthalmology Drugs & Devices Price by Manufacturers
• 3.4 Key Manufacturers Ophthalmology Drugs & Devices Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Ophthalmology Drugs & Devices Market
• 3.6 Key Manufacturers Ophthalmology Drugs & Devices Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Diagnostic and monitoring devices Production and Production Value (2014-2019)
  • 4.1.2 Surgical devices Production and Production Value (2014-2019)
  • 4.1.3 Vision care Production and Production Value (2014-2019)
  • 4.1.4 Drugs Production and Production Value (2014-2019)
• 4.2 Global Ophthalmology Drugs & Devices Production Market Share by Type
• 4.3 Global Ophthalmology Drugs & Devices Production Value Market Share by Type
• 4.4 Ophthalmology Drugs & Devices Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Ophthalmology Drugs & Devices Consumption by Application

6 Production by Regions

• 6.1 Global Ophthalmology Drugs & Devices Production (History Data) by Regions 2014-2019
• 6.2 Global Ophthalmology Drugs & Devices Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Ophthalmology Drugs & Devices Production Growth Rate 2014-2019
  • 6.3.2 United States Ophthalmology Drugs & Devices Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Ophthalmology Drugs & Devices Import & Export
• 6.4 European Union
  • 6.4.1 European Union Ophthalmology Drugs & Devices Production Growth Rate 2014-2019
  • 6.4.2 European Union Ophthalmology Drugs & Devices Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Ophthalmology Drugs & Devices Import & Export
• 6.5 China
  • 6.5.1 China Ophthalmology Drugs & Devices Production Growth Rate 2014-2019
  • 6.5.2 China Ophthalmology Drugs & Devices Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Ophthalmology Drugs & Devices Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Ophthalmology Drugs & Devices Consumption by Regions

• 7.1 Global Ophthalmology Drugs & Devices Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Ophthalmology Drugs & Devices Consumption by Type
  • 7.2.2 United States Ophthalmology Drugs & Devices Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Ophthalmology Drugs & Devices Consumption by Type
  • 7.3.2 European Union Ophthalmology Drugs & Devices Consumption by Application
• 7.4 China
  • 7.4.1 China Ophthalmology Drugs & Devices Consumption by Type
  • 7.4.2 China Ophthalmology Drugs & Devices Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Ophthalmology Drugs & Devices Consumption by Type
  • 7.5.2 Rest of World Ophthalmology Drugs & Devices Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Abbott
  • 8.1.1 Abbott Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.1.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.1.5 Abbott Recent Development
• 8.2 Alcon
  • 8.2.1 Alcon Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.2.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.2.5 Alcon Recent Development
• 8.3 Allergan
  • 8.3.1 Allergan Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.3.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.3.5 Allergan Recent Development
• 8.4 Bausch & Lomb
  • 8.4.1 Bausch & Lomb Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.4.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.4.5 Bausch & Lomb Recent Development
• 8.5 Carl Zeiss Meditec
  • 8.5.1 Carl Zeiss Meditec Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.5.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.5.5 Carl Zeiss Meditec Recent Development
• 8.6 Ellex
  • 8.6.1 Ellex Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.6.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.6.5 Ellex Recent Development
• 8.7 Essilor
  • 8.7.1 Essilor Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.7.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.7.5 Essilor Recent Development
• 8.8 Hoya
  • 8.8.1 Hoya Company Details
  • 8.8.2 Company Description and Business Overview
  • 8.8.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.8.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.8.5 Hoya Recent Development
• 8.9 Iridex
  • 8.9.1 Iridex Company Details
  • 8.9.2 Company Description and Business Overview
  • 8.9.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.9.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.9.5 Iridex Recent Development
• 8.10 Johnson & Johnson
  • 8.10.1 Johnson & Johnson Company Details
  • 8.10.2 Company Description and Business Overview
  • 8.10.3 Production and Revenue of Ophthalmology Drugs & Devices
  • 8.10.4 Ophthalmology Drugs & Devices Product Introduction
  • 8.10.5 Johnson & Johnson Recent Development
• 8.11 Merck & Co.
• 8.12 Nidek Co.
• 8.13 Santen Pharmaceutical
• 8.14 Novartis
• 8.15 Pfizer
• 8.16 Roche Holding
• 8.17 Staar Surgical
• 8.18 Topcon
• 8.19 Ziemer Ophthalmic Systems

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Ophthalmology Drugs & Devices Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Ophthalmology Drugs & Devices Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Ophthalmology Drugs & Devices Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Ophthalmology Drugs & Devices Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Ophthalmology Drugs & Devices Production Forecast by Type
  • 9.7.2 Global Ophthalmology Drugs & Devices Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Ophthalmology Drugs & Devices Sales Channels
  • 10.2.2 Ophthalmology Drugs & Devices Distributors
• 10.3 Ophthalmology Drugs & Devices Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

Ophthalmology is a branch of medicine and surgery (both methods are used) that deals with the anatomy, physiology and diseases of the eyeball and orbit. Ophthalmic Equipment are the tool used for ophthalmology.
The growth of this market is primarily due to the rapid growth in the geriatric population, rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment.
In 2019, the market size of Ophthalmology Drugs & Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ophthalmology Drugs & Devices.

This report studies the global market size of Ophthalmology Drugs & Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ophthalmology Drugs & Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abbott
Alcon
Allergan
Bausch & Lomb
Carl Zeiss Meditec
Ellex  
Essilor  
Hoya
Iridex
Johnson & Johnson 
Merck & Co. 
Nidek Co. 
Santen Pharmaceutical  
Novartis
Pfizer    
Roche Holding 
Staar Surgical
Topcon
Ziemer Ophthalmic Systems

Market Segment by Product Type
Diagnostic and monitoring devices
Surgical devices
Vision care
Drugs

Market Segment by Application
Cataract
Glaucoma
Refractive error
Vitreoretinal

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Ophthalmology Drugs & Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ophthalmology Drugs & Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Ophthalmology Drugs & Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025